LATTICE MEDICAL

LATTICE MEDICAL is a French biomedical start-up founded in 2017, specializing in tissue engineering and 3D printing technologies. The company focuses on developing innovative solutions for soft tissue regeneration, particularly in breast reconstruction after cancer treatment. Their flagship product, MATTISSE, is a patented, bio-resorbable 3D-printed implant that supports natural breast tissue regeneration using the patient's own fat tissue. This approach minimizes the need for multiple surgeries and reduces patient risk and healthcare costs. In addition to MATTISSE, LATTICE MEDICAL is creating a digital platform to assist surgeons in selecting the appropriate implant size and generating custom-made prostheses tailored to each patient's anatomy. The company also operates LATTICE SERVICES, which designs and produces medical-grade 3D printing filaments for tissue engineering applications. LATTICE MEDICAL collaborates with medical institutions and engages in research to validate the safety and efficacy of their devices, aiming to enhance the quality of care for oncology patients undergoing mastectomy.

• Employees 29
• Founded 2017
• Total Funding $2623609